Search Results - "Hashemyan, Maneja"

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts by Reis, Bernhard, Jukofsky, Lori, Chen, Gong, Martinelli, Giovanni, Zhong, Hua, So, W Venus, Dickinson, Michael J, Drummond, Mark, Assouline, Sarit, Hashemyan, Maneja, Theron, Michel, Blotner, Steven, Lee, Je-Hwan, Kasner, Margaret, Yoon, Sung-Soo, Rueger, Ruediger, Seiter, Karen, Middleton, Steven A, Kelly, Kevin R, Vey, Norbert, Yee, Karen, Nichols, Gwen, Chen, Lin-Chi, Pierceall, William E

Get full text

Clinical Response to Idasanutlin (RG7388) in Acute Myeloid Leukemia Patients Is Associated with Pre-Treatment MDM2 Protein Expression in Leukemic Blasts and Leukemic Stem Cells by Reis, Bernhard, Jukofsky, Lori, Chen, Gong, Martinelli, Giovanni, Zhong, Hua, So, Venus, Dickinson, Michael J., Drummond, Mark W., Assouline, Sarit E., Hashemyan, Maneja, Theron, Michel, Blotner, Steven, Lee, Je-Hwan, Kasner, Margaret, Yoon, Sung-Soo, Rueger, Ruediger, Seiter, Karen, Middleton, Steven, Kelly, Kevin R., Vey, Norbert, Yee, Karen W.L., Nichols, Gwen, Chen, Lin-Chi, Pierceall, William E.

“…Introduction. Despite years of translational research and discovery, outcomes in Acute Myeloid Leukemia remain poor. The MDM2 antagonist idasanutlin has shown…”
Get full text